Nomic Bio at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
Nomic Bio takes part in 3 sessions at ACT 2026 in San Antonio. Its program centres on high-throughput protein measurement as a richer readout than standard cell-death assays for lab-grown models such as organoids and tissue slices. It also shows protein profiles that separate mechanisms of liver toxicity and predict liver injury in patients.
| Organization | ACT 2026 Attendance |
|---|---|
Nomic Bio Montreal, QC, Canada | |
Montreal proteomics company running high-throughput protein profiling with its nELISA technology, used here to read toxicity markers from in vitro models. | Poster Mon Nov 16 5:00pm–6:30pm Poster Mon Nov 16 5:00pm–6:30pm |
Instantly find 20 buyers from Nomic Bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction